Immune Cell Therapy (CAR-T) for the Treatment of Patients With HIV and B-Cell Non-Hodgkin Lymphoma
Conditions
AIDS-Related Diffuse Large B-cell Lymphoma · AIDS-Related Non-Hodgkin Lymphoma · HIV Infection · Recurrent Diffuse Large B-Cell Lymphoma · Recurrent Grade 3b Follicular Lymphoma · Recurrent High Grade B-Cell Lymphoma · Recurrent Non-Hodgkin Lymphoma · Recurrent Primary Mediastinal (Thymic) Large B-Cell Lymphoma · Recurrent Transformed B-Cell Non-Hodgkin Lymphoma · Refractory Diffuse Large B-Cell Lymphoma · Refractory Grade 3b Follicular Lymphoma · Refractory High Grade B-Cell Lymphoma · Refractory Non-Hodgkin Lymphoma · Refractory Primary Mediastinal (Thymic) Large B-Cell Lymphoma · Refractory Transformed B-Cell Non-Hodgkin Lymphoma
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
City of Hope Comprehensive Cancer Center, Duarte, California, United States
Contact: Principal Investigator (John Baird, MD)University of Illinois at Chicago, Chicago, Illinois, United States
Contact: Principal Investigator (Paul Rubinstein, MD)Memorial Sloan Kettering Cancer Center, New York, New York, United States
Contact: Principal Investigator (Maria Palomba, MD)Montefiore Medical Center - Moses Campus, The Bronx, New York, United States
Contact: Principal Investigator (Lauren Shapiro, MD)The Ohio state University, Columbus, Ohio, United States
Contact: Principal Investigator (Polina Shindiapina, Phd,MD,BS)University of Pennsylvania / Abramson Cancer Center, Philadelphia, Pennsylvania, United States
Contact: Study coordinator (Kaitlin Kennard) · kaitlin.kennard@pennmedicine.upenn.edu · 267-804-4080Contact: Principal Investigator (Colin Thomas, MD)Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah, United States
Contact: Principal Investigator (Margaret K Baron, MD)
Study leads
Ariela Noy
Principal Investigator
AIDS Malignancy Consortium